Gemigliptin
Sponsors
LG Life Sciences, Seoul National University Hospital, Seoul National University Bundang Hospital, Stendhal Americas, S.A., LG Chem
Conditions
AcarboseCancerCisplatin Adverse ReactionDiabetes Mellitus, Type 2Diabetic NephropathiesEjection FractionEndothelial FunctionGemigliptin
Phase 1
Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects
CompletedNCT01825850
Start: 2013-06-30End: 2014-03-31Updated: 2014-12-30
Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White Volunteers
CompletedNCT02004587
Start: 2013-09-30End: 2014-07-31Target: 28Updated: 2014-07-14
An Assessment of Pharmacokinetic Gemigliptin and Metformin Interactions in Healthy Mexican Volunteers
CompletedNCT03310749
Start: 2016-01-15End: 2016-05-03Updated: 2017-10-16
Gemigliptin, Dapagliflozin, Empagliflozin DDI Study
NCT03565458
Start: 2018-04-05End: 2018-12-22Updated: 2018-06-21
Phase 2
Phase 3
A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study)
CompletedNCT01968044
Start: 2013-10-31End: 2015-10-31Updated: 2016-03-23
Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin
CompletedNCT01990469
Start: 2014-01-31End: 2015-04-30Updated: 2016-04-19
Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)
CompletedNCT02831361
Start: 2016-10-17End: 2018-02-08Updated: 2018-02-22
Phase 4
Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients
NCT02500329
Start: 2014-09-30Target: 54Updated: 2015-07-16
Comparison of the Effects of Dapagliflozin and Gemigliptin on Ketone Metabolism and Cardiac Remodeling in Type 2 Diabetes
NCT05194592
Start: 2022-01-07End: 2025-06-30Target: 122Updated: 2023-08-01
Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 Diabetes
NCT05663736
Start: 2020-01-01End: 2023-12-31Target: 80Updated: 2023-03-08
Unknown Phase
Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia
CompletedNCT02186080
Start: 2014-07-31End: 2015-07-31Updated: 2016-04-21
An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin
CompletedNCT02290301
Start: 2013-06-28End: 2017-11-30Updated: 2019-01-24
Gemigliptin and Biomarkers of Kidney Injury and Vascular Calcification
CompletedNCT04705506
Start: 2017-02-05End: 2019-03-01Updated: 2021-01-14